Skip to main content

Table 1 Main results: 12-month follow-up after bone marrow cell application (n = 62)

From: Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia

Outcome

 

Mortality

7/62 (11 %)

Amputation-free survival

39/62 (63 %)

Limb salvage

39/55 (71 %)

Limb salvage + wound healing

33/55 (60 %)